Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions highlight strong agreement with the study's results, such as references to the NEJM publication and the STOP-IT trial, showing that short courses (around 4 days) are as effective as longer treatments. The tone and choice of words, like 'game changer,' and references to clinical guidelines underscore the high relevance and potential influence on antibiotic stewardship policies.
Most discussions support the findings of the study, emphasizing that shorter antibiotic courses are adequate after source control.
The majority of posts show high interest by referencing specific trials, guidelines, and clinical practices impacted by the study.
Many posts delve into detailed implications, share personal clinical experiences, and discuss how this evidence influences treatment decisions.
Considering the frequent mention of guidelines, changes in clinical practice, and universal support, the discussions suggest the study's findings have high clinical and stewardship impact.
@MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection comes up frequently. The STOP-IT trial is a must read. Link: https://t.co/H1QpaMY5Yk Credit to Mathieu Larouche for the first pic. https://t.co/9tRXV8X5qz
D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotics have similar outcomes to longer courses. Read the STOP-IT trial published in @NEJM https://t.co/9fL18K4WkU
@Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Duke_Anesthesia @iwashyna @TomVargheseJr And if you take care of surgical ICU patients, STOP-IT Sawyer et al. @NEJM 2015 https://t.co/D12kexxpVy
Back on service! Day #1 ID learning: The top-line results of the STOP-IT trial (https://t.co/vd8GsSACMo) look great. 4 days of abx was equivalent to longer for complicated intra-abdominal infx. So why do most of our patient gets more than 4 days of abx?
3. Duration of tx is another frequent consult question. I found myself frequently referring to the "Shorter is Better" @BradSpellberg (https://t.co/rJdVrx2Ers). STOP-IT is 1 example of an important RCT examining duration for intra-abdominal infxn (https://t.co/8Sobw6Mgk5). (4/12)
#TrialOfTheDay for May 21st is the STOP-IT trial. Longer isn't necessarily better as it relates to antimicrobial use Open-access article link: https://t.co/CUKCUOnOyV #pharmicu #twitterx #idtwitter #medtwitter #foamcc #pharmacy #pharmacist #criticalcare #some #meded https://t.co/fHQ6mHhwS4
The NEJM Quick Take discusses a trial comparing short-course (around 4 days) versus longer antibiotic therapy (up to 8 days) in intraabdominal infections. Results show similar outcomes, indicating shorter courses may…
This episode discusses postoperative care, including managing common issues like hypotension, tachycardia, and fever, with emphasis on clinical assessments, imaging, and laboratory tests to ensure effective diagnosis…
2/ Well established that in IAI pts with effective source control short course abx therapy works! #STOPIT Problem arises when pts don't meet those inclusion criteria, often due to unable to get source control. What to do in those pts w abx? https://t.co/mR9ivd5Dbh
STOP-IT trial (2015): https://t.co/AsVSODVawd DURAPOP trial (2018): https://t.co/J8IIaUi8UT @BWDionne @jeffpears0n @davidwkubiak @SikandarIDAPPE @_michelleyu Happy Friday, everyone!
Se alguém tiver algum desses, me manda POR FAVOR https://t.co/QdAexKn9Hu https://t.co/RDfAGQmcir
@johnkops Μην έχεις καμία αμφιβολία ότι όσοι χειρουργοί έχουμε κάνει ειδικότητα σε κανονικές χώρες ξέρουμε να χρησιμοποιούμε τα αντιβιοτικά σε χειρουργικούς ασθενείς απείρως καλύτερα από εντατικολόγους κ λοιμωξιολόγους. Άσχετο αυτό με την προκήρυξη του ΕΟΔΥ βέβαια. https://t.co/eNjQOo7LeV https://t.co/L1EQRRZsB8
RT @SusanaFortichS: Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/hJMMAfCcvc
Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/hJMMAfCcvc
Leave it to ID doctors to be creative with RCT names: just learned about STOP-IT, which showed a fixed 4-day course of abx was just as good as a longer (~8 day) course for intraabdominal infections after achieving source control https://t.co/wdhDDvHgmV
@Paul_Wischmeyer @TopKniFe_B @NEJM @nickmmark @drdangayach @laxswamy @iceman_ex @chungk1031 @iamyourgasman @brownam130 @YukiKotani5 @FOAMecmo @IM_Crit_ STOP-IT - https://t.co/VKjInDRZIL
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
@EdoajoEric 12 yrs later: orals get cheaper. Now default is all pts get pills as soon as possible, absent some med reason for IV… This study seems to make the case for that, but the sponsors wont surprise u https://t.co/NzJFwYoO9x
#OTILT in intra-abdominal infections after achieving source control the outcomes for shorter courses (~4 days) of antibiotics were similar to longer courses (~8 days) @armandbak @BWDionne @jeffpears0n @davidwkubiak https://t.co/T0lsS2nFNL
RT @PharmacyToDose: #TrialOfTheDay for May 21st is the STOP-IT trial. Longer isn't necessarily better as it relates to antimicrobial use…
RT @PharmacyToDose: #TrialOfTheDay for May 21st is the STOP-IT trial. Longer isn't necessarily better as it relates to antimicrobial use…
#TrialOfTheDay for May 21st is the STOP-IT trial. Longer isn't necessarily better as it relates to antimicrobial use Open-access article link: https://t.co/CUKCUOnOyV #pharmicu #twitterx #idtwitter #medtwitter #foamcc #pharmacy #pharmacist #criticalcare #some #meded https://t.co/fHQ6mHhwS4
RT @PharmDFarmD: Up first, the basis for the 4-day recommendation - the STOP-IT trial. 518 patients in an RCT comparing a fixed 3-5 day c…
RT @PharmDFarmD: Up first, the basis for the 4-day recommendation - the STOP-IT trial. 518 patients in an RCT comparing a fixed 3-5 day c…
Up first, the basis for the 4-day recommendation - the STOP-IT trial. 518 patients in an RCT comparing a fixed 3-5 day course vs a maximum of 10 days (2 days after resolution of fever, WBC, and ileus, mean 8 day course) for a variety of IAIs https://t.co/igdMwOrVPZ
RT @SDGraceYoung: @PonziniF @SSATNews @AmCollSurgeons @SAGES_Updates @AcademicSurgery @SurgJournal STOP-IT ! I got asked about this one at…
RT @SDGraceYoung: @PonziniF @SSATNews @AmCollSurgeons @SAGES_Updates @AcademicSurgery @SurgJournal STOP-IT ! I got asked about this one at…
@PonziniF @SSATNews @AmCollSurgeons @SAGES_Updates @AcademicSurgery @SurgJournal STOP-IT ! I got asked about this one at two different sub-Is. https://t.co/sEZ7ZgpT3e
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @JerryDangMD: @AmJSurgery @SWexner @juliomayol @PipeCabreraV @Cirbosque @pferrada1 @TomVargheseJr @herbchen @salo75 @LiangRhea This is a…
@AmJSurgery @SWexner @juliomayol @PipeCabreraV @Cirbosque @pferrada1 @TomVargheseJr @herbchen @salo75 @LiangRhea This is a nice algorithm but why 4 to 7 days of antibiotics after adequate source control? The STOP-IT trial demonstrated that 4 +/- 1 day of antibiotics was sufficient. https://t.co/PF5BhlYvjX
RT @sefh_: RT @Olguitxi "Para optimizar el uso de antibióticos controla la duración de los tratamientos …" http://t.co/Lu9XkxmM5k
Patients with intra-abdominal infections who have had adequate source control treated with 4 days of antibiotics showed similar outcomes to those treated with 8 days of antibiotics. https://t.co/Qnl3LKrfse
@PrathitKulkarni https://t.co/pgZ7mw6rCt
Practical
https://t.co/JIsuQmoVab
We read the 2015 NEJM STOP-IT which empowered us to discontinue antibiotics earlier than planned in a patient with abdominal infection after source control https://t.co/9uMnmtrsbS (10/X)
STOP-IT Trial has a short video: https://t.co/lvScw5YlPT. TL;DR, @markteeherb summarizes that 3-5 days of abx didn’t have higher rates of surgical-site infection, recurrent intra-abdominal infection or death compared to abx until 2 days after symptom resolution. #ACPOhio22 https://t.co/rhCeD3NcCr
@eeeejjjaaaa ... which are 100% of the cases we get consulted on, making the STOP-IT trial of painfully limited use to ID docs! https://t.co/MWFs7XSolh
#colloid vs. #crystalloid in #sepsis with #cirrhosis? https://t.co/QlkgYH8BDP Antibiotic duration in controlled abdominal infections: STOP-IT trial: https://t.co/zivWUKJq8m No cuff-leak. Do we extubate? A nice practical approach by @PulmCrit : https://t.co/N6TeKd7fAJ.
RT @CAGS_ACCG: @NEJM RCT comparing short course (4±1days) vs standard #antibiotic duration therapy (≤10 days) following source control for…
https://t.co/5jzhvFCglA
@BarnerIDpharmD @moore_wjustin @accpinfdprn What most of us have yelled at least once a day: STOP-IT. Bonus: trial investigators = some of the coolest antimicrobial stewardship surgeons https://t.co/XhABhIWSa9 https://t.co/6y9BrVD7ZJ
@BWDionne https://t.co/WJDg8z3bcW
In patients with intraabdominal infections who had undergone an adequate source-control procedure, the outcomes after fixed-duration antibiotic therapy (approximately 4 days) were similar to those after a longer course of antibiotics (approximately 8 days) https://t.co/gToGoCxib7
@BradSpellberg @ABsteward I love it! Was hoping to get brought down this avenue! I make this push for every #SICU and #TICU patient with secondary or tertiary #peritonitis ; and as #diverticulitis is all about #microperforations… I couldn’t agree more! https://t.co/W794eTArQz
@CW_Pharmacists T4: Highlighting the potential adverse outcomes of prolonging antibiotic therapy in clinical trials. The STOP-IT trial authors (https://t.co/gQQGDX7P3u) argued that prolonging antibiotic therapy may prolong time to recognition of infectious complications #CPApharm
Check out the STOP-IT trial which supports short-course antimicrobial therapy for intraabdominal infection following source-control procedure. #PITT_ID21 https://t.co/zAV4gXwY9F
@rbarbosa91 @SAGES_Updates @docmartin22 @VNikolian @TsengJennifer @MackenzieCookMD @doc_on_the_run https://t.co/8CSkhynMh1
The IDSA guidelines recommend 4-7 days of antibiotics for complicated intra-abdominal infection. With source control, antibiotics may be discontinued after 4 days as longer duration may not improve outcomes. #OTILT @BWDionne @jeffpears0n @davidwkubiak https://t.co/Gz2DfUD0qw
# medtwitter #idrotation Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/O42WBf7HZG
RT @AMTatara: 3. Duration of tx is another frequent consult question. I found myself frequently referring to the "Shorter is Better" @BradS…
3. Duration of tx is another frequent consult question. I found myself frequently referring to the "Shorter is Better" @BradSpellberg (https://t.co/rJdVrx2Ers). STOP-IT is 1 example of an important RCT examining duration for intra-abdominal infxn (https://t.co/8Sobw6Mgk5). (4/12)
#OTILT The STOP-IT trial demonstrated that a short abx course (median 4 days) achieved similar efficacy outcomes in patients with intra-adominal infections and adequate source control compared to a longer course (median 8 days). https://t.co/rYVchz5cCW @SarahPharmacy @BWDionne
RT @JakeJohnsonMD: Back on service! Day #1 ID learning: The top-line results of the STOP-IT trial (https://t.co/vd8GsSACMo) look great. 4 d…
RT @JakeJohnsonMD: Back on service! Day #1 ID learning: The top-line results of the STOP-IT trial (https://t.co/vd8GsSACMo) look great. 4 d…
Back on service! Day #1 ID learning: The top-line results of the STOP-IT trial (https://t.co/vd8GsSACMo) look great. 4 days of abx was equivalent to longer for complicated intra-abdominal infx. So why do most of our patient gets more than 4 days of abx?
Trial of short-course antimicrobial therapy for intraabdominal infection https://t.co/27L4C9wRry
https://t.co/gqBUmEuQGD
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
RT @EricKnauerMD: @MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection…
@MISIRG1 @Cirbosque @cutitoutPODCAS1 @ChaseSurgical The question of duration of antibiotics for intra-abdominal infection comes up frequently. The STOP-IT trial is a must read. Link: https://t.co/H1QpaMY5Yk Credit to Mathieu Larouche for the first pic. https://t.co/9tRXV8X5qz
@BRxAD @ASP_Chat Concur!! Low hanging fruit but I’ll also add IAI to this.. My tag line “Oh just STOP it” https://t.co/ZiOxd1dyyT. #ASPChat
RT @TaehyeonKim13: #OTILTD For patient with complicated intraabdominal infection with adequate source control, source term (4 days) antibio…
#OTILTD For patient with complicated intraabdominal infection with adequate source control, source term (4 days) antibiotic therapy had similar outcomes as those who had longer course of antibiotic therapy @BWDionne @eviebeckert https://t.co/JCsNOgTDO3
Peds ID Day 4: Consult for a child with an abdominal catastrophe and abdominal abscess after surgery. The power of draining pus! #IDTwitter Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection https://t.co/yeXZAFjPzU
The STOP-IT trial found that in patients with intra-abdominal infections with source control a 3-5 day course was equally as effective as continuing ABX for 2 days after fever and leukocytosis had subsided. #otilt #antimicrobialstewardship Read more
Always good to keep a repertoire of studies on abx duration (in particular when evidence might point to shorter courses!) Intra-abd infections 4vs 8 day course, STOP-IT trial https://t.co/XXLWYf53eX
Source: https://t.co/HdwEzvVtBs
RT @heatherevansmd: @Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Du…
RT @heatherevansmd: @Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Du…
RT @heatherevansmd: @Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Du…
RT @heatherevansmd: @Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Du…
RT @heatherevansmd: @Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Du…
@Paul_Wischmeyer @NEJM @DrDaleNeedham @gsmartinmd @SapnaKmd @SICUPharmD @toddrice_ICU @SCCMPresident @Fluid_Academy @Duke_Anesthesia @iwashyna @TomVargheseJr And if you take care of surgical ICU patients, STOP-IT Sawyer et al. @NEJM 2015 https://t.co/D12kexxpVy
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
RT @CarlosdelRio7: D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotic…
D#7. In patients with intraabdominal infections who have gotten adequate source control, a shorter course of antibiotics have similar outcomes to longer courses. Read the STOP-IT trial published in @NEJM https://t.co/9fL18K4WkU
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @chriskc_Lee: 4 days antibiotic therapy not inferior to 8 days therapy for patients who have undergone adequate source control for intra…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
4 days antibiotic therapy not inferior to 8 days therapy for patients who have undergone adequate source control for intraabd infections. Another possibility of decreasing antibiotic use. #AMR #Sepsis https://t.co/7ecTK8yAQ9
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
RT @PaulSaxMD: Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferio…
腹腔内感染症の短期投与、長期投与 Trial of short-course antimicrobial therapy for intraabdominal infection. - PubMed - NCBI https://t.co/WdMdH7Zvz2
Antibióticos x 4d en pacientes con infecciones inbtraabdominales con fuente anatómica controlada tan efectivos como esquemas convencionales de al menos 8d Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/ryKKrsZA6l
RT @WakeACS: Great conversation this past week at our monthly journal club on infectious disease in critical illness! @traumadoctors @NCSur…
Great conversation this past week at our monthly journal club on infectious disease in critical illness! @traumadoctors @NCSurgeons @EAST_TRAUMA @wakeforestmed @wakehealth Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/Es92naviZV
Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/1gjFRKWNKq
RT @Grupo_AFinf_SEF: Seguimos con la evidencia sobre ttos cortos en IIA. Todo esto lo repasamos ayer en Taller #VINCat con Dra. Membrilla.…
RT @Grupo_AFinf_SEF: Seguimos con la evidencia sobre ttos cortos en IIA. Todo esto lo repasamos ayer en Taller #VINCat con Dra. Membrilla.…
RT @Grupo_AFinf_SEF: Seguimos con la evidencia sobre ttos cortos en IIA. Todo esto lo repasamos ayer en Taller #VINCat con Dra. Membrilla.…
RT @Grupo_AFinf_SEF: Seguimos con la evidencia sobre ttos cortos en IIA. Todo esto lo repasamos ayer en Taller #VINCat con Dra. Membrilla.…
Seguimos con la evidencia sobre ttos cortos en IIA. Todo esto lo repasamos ayer en Taller #VINCat con Dra. Membrilla. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection | NEJM https://t.co/Sr76nDepcT
EK
CR
HF
JJ
AP
PP
BF
SJ
AP
B
YM
SM
JG
NS
J
JD
R
P
PN
RS
DP
AB
NK
S
GY
CS
JM
JP
MG
AP
SN
MA
RF
RB
PS
GK
AF
FJ
DC
ح
JC
MP
LM
NN
V
R
EH
MF
I
ソ
LM
CP
CW
MC
NN
CM
NA
GA
T
DF
AL
AL
R
SM
AH
MS
MM
RD
EB
MS
JN
ID
AK
JG
SC
SN
TG
PM
A
JC
SS
T
SS
B
ID
CB
BC
DF
A
LM
PM
SN
WM
SU
PM
GC
BG
GS
JC
JR
MA
NZ
ÖE
CL
FA
BL
LF
ぽ
IU
NA
WS
SA
MM
C
PI
L
GS